Prediction of the Anti-Parkinson’s Effect of Phytoconstituents from Mucuna Pruriens with the use of Prediction of Activities Spectra of Substances Software

References

• (PDF) In Vitro evaluation of the antibacterial activity of Mucuna pruriens leaf and callus extracts. (n.d.). Retrieved April 5, 2023, from http://www.researchgate.net/publication/263311975_In_Vitro_evaluation_of_the_antibacterial_activity_of_Mucuna_pruriens_leaf_ and_callus_extracts
• (PDF) Phytochemistry and pharmacological activity of Mucuna pruriens: A review. (n.d.). Retrieved April 5, 2023, from https://www.researchgate.net/publication/317304163_Phytochemistry_and_ pharmacological_activity_of_Mucuna_pruriens_A_review
• (PDF) Review on “Mucuna” - The wonder plant. (n.d.). Retrieved April 5, 2023, from https://www.researchgate.net/publication/287916753_Review_ on_Mucuna_-_The_wonder_plant5-Hydroxy tryptophan. (n.d.).
• Antonini, A., Poewe, W., Chaudhuri, K. R., Jech, R., Pickut, B., Pirto Sek G, Z., Szasz, J., Valldeoriola, F., Winkler, C., Bergmann, L., Yegin, A., Onuk, K., & Barch, D. (2017). Levodopa-carbidopa intestinal gel in advanced Parkinson’s: Final results of the GLORIA registry. Parkinsonism and Related Disorders, 45, 13–20. https://doi.org/10.1016/j.parkreldis.2017.09.018
• Armstrong, M. J., & Okun, M. S. (2020). Diagnosis and Treatment of Parkinson Disease: A Review. JAMA, 323(6), 548–560. https://doi.org/10.1001/JAMA.2019.22360
• Badhani, B., Sharma, N., & Kakkar, R. (2015). Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications. RSC Advances, 5(35), 27540–27557. https://doi.org/10.1039/C5RA01911G
• Bajracharya, R., Bustamante, S., & Ballard, J. W. O. (2019). Stearic Acid Supplementation in High Protein to Carbohydrate (P:C) Ratio Diet Improves Physiological and Mitochondrial Functions of Drosophila melanogaster parkin Null Mutants. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 74(10), 1564–1572. https://doi.org/10.1093/GERONA/GLX246
• Bufotenin oxide | C12H16N2O2 - PubChem. (n.d.). Retrieved April 5, 2023, from https://pubchem.ncbi. nlm.nih.gov/compound/Bufotenin-oxide
• Calzetti, S., & Negrotti, A. (2023). Permanent non- progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly? Journal of the Neurological Sciences, 444, 120526. https://doi.org/10.1016/J.JNS.2022.120526
• Charleston, S. S., & Clegg, K. M. (1972). ASCORBIC ACID AND THE COMMON COLD. The Lancet, 299(7765), 1401–1402. https://doi.org/10.1016/S0140-6736(72)91143-9
• Farnsworth, N. R., Akerele, O., Bingel, A. S., Soejarto, D. D., & Guo, Z. (1985). Medicinal plants in therapy. Bulletin of the World Health Organization, 63(6), 965. https://doi.org/10.1016/0378-8741(87)90016-x
• High Levels of Levodopa Found in Mucuna Pruriens Supplements | Mucuna Pruriens Supplements May Lead to Excess Levodopa in Patients | Parkinson’s News Today. (n.d.). Retrieved March 30, 2023, from https:// parkinsonsnewstoday.com/news/high-levels-levodopa- found-mucuna-pruriens-supplements/
• Iderberg, H., McCreary, A. C., Varney, M. A., Cenci, M. A., & Newman-Tancredi, A. (2015). Activity of serotonin 5-HT(1A) receptor “biased agonists” in rat models of Parkinson’s disease and L-DOPA-induced dyskinesia. Neuropharmacology, 93, 52–67. https:// doi.org/10.1016/J.NEUROPHARM.2015.01.012
• Ishikawa, S., Taira, T., Niki, T., Takahashi-Niki, K., Maita, C., Maita, H., Ariga, H., & Iguchi-Ariga, S. M. M. (2009). Oxidative status of DJ-1-dependent activation of dopamine synthesis through interaction of tyrosine hydroxylase  and 4-dihydroxy-L-phenylalanine (L-DOPA) decarboxylase with DJ-1. The Journal of Biological Chemistry, 284(42), 8832–28844. https://doi.org/10.1074/JBC.M109.019950
• James, E., Keppler, J., L Robertshaw, T., & Sessa, B. (2022).             N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Human Psychopharmacology: Clinical and Experimental, 37(3), e2835. https://doi.org/10.1002/HUP.2835
• Johnson, G. H., & Fritsche, K. (2012). Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. Journal of the Academy of Nutrition and Dietetics, 112(7). https://doi.org/10.1016/J.JAND.2012.03.029
• Kabuto, H., Yamanushi, T. T., Janjua, N., Takayama, F., & Mankura, M. (2013). Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson’s disease mouse model. Journal of Oleo Science, 62(1), 21–28. https://doi.org/10.5650/JOS.62.21
• Katzenschlager, R., & Lees, A. J. (2002). Treatment of Parkinson’s disease: levodopa as the first choice. Journal of Neurology, 249 Suppl 2(2). https://doi.org/10.1007/S00415-002-1204-4
• Katzenshlager, R., Evans, A., Manson, A., Palsalos, P. N., Ratnaraj, N., Watt, H., Timmermann, L., Van Der Giessen, R., & Lees, A. J. (2004). Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study. Journal of Neurology, Neurosurgery & Psychiatry, 75(12), 1672–1677. https://doi.org/10.1136/JNNP.2003.028761
• Kim, Y. C. (2010). Neuroprotective phenolics in medicinal plants. Archives of Pharmacal Research, 33(10), 1611– 1632. https://doi.org/10.1007/S12272-010-1011-X
• Kumar, P., & Saha, S. (2013). An updated review on Taxonomy, Phytochemistry, Pharmacology and Toxicology of Macuna Pruriens. Journal of Pharmacognosy and Phytochemistry, 2(1), 306–314. https://www.phytojournal.com/archives/2013. v2.i1.636/an-updated-review-on-taxonomy- phytochemistry-pharmacology-and-toxicology-of- macuna-pruriens
• Kumar, R., Kumar, R., Anand, A., Sharma, N., & Khurana, N. (2018). Prediction of Anti-Parkinson Potential of Phytoconstituents using Prediction of Activity Spectra of Substances Software. Asian Journal of Pharmaceutical and Clinical Research, 11(Special Issue 2), 48–56. https://doi.org/10.22159/AJPCR.2018.V11S2.28578
• Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. (2000). PASS: prediction of activity spectra for biologically active substances. Bioinformatics, 16(8), 747–748. https://doi.org/10.1093/ BIOINFORMATICS/16.8.747
• Lampariello, L., Cortelazzo, A., Guerranti, R., Sticozzi, C., & Valacchi, G. (2012). The Magic Velvet Bean of Mucuna pruriens. Journal of Traditional and Complementary Medicine, 2(4), 331. https://doi.org/10.1016/S2225-4110(16)30119-5
• Lanoue, A. C., Dumitriu, A., Myers, R. H., & Soghomonian, J. J. (2010). Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson’s disease. Experimental Neurology, 226(1), 207. https:/doi.org/10.1016/J.EXPNEUROL.2010.09.001
• Levodopa. (n.d.). https://pubchem.ncbi.nlm.nih.gov/ compound/Levodopa
• Lopez, S., Bermudez, B., Pacheco, Y. M., Ortega, A., Varela, L. M., Abia, R., & Muriana, F. J. G. (2010). Oleic Acid: The Main Component of Olive Oil on Postprandial Metabolic Processes. Olives and Olive Oil in Health and Disease Prevention, 1385–1393. https:// doi.org/10.1016/B978-0-12-374420-3.00154-6
• Mack, J. M., Schamne, M. G., Sampaio, T. B., Pértile, R. A. N., Fernandes, P. A. C. M., Markus, R. P., & Prediger, R. D. (2016). Melatoninergic System in Parkinson’s Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms. Oxidative Medicine and Cellular Longevity, 2016. https://doi.org/10.1155/2016/3472032
• Martínez-Banaclocha, M. A. (2012). N-acetyl-cysteine in the treatment of Parkinson’s disease. What are we waiting for? Medical Hypotheses, 79(1), 8–12. https://doi.org/10.1016/J.MEHY.2012.03.021
• Matsubara, K., Aoyama, K., Suno, M., & Awaya, T. (2002). N-methylation underlying Parkinson’s disease. Neurotoxicology and Teratology, 24(5), 593–598. https://doi.org/10.1016/S0892-0362(02)00212-X
• Meloni, M., Puligheddu, M., Carta, M., Cannas, A., Figorilli, M., & Defazio, G. (2020). Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson’s disease: a preliminary finding. European Journal of Neurology, 27(5), 779–786. https://doi.org/10.1111/ENE.14179
• Metzdorf, J., & Tönges, L. (2021). Short-chain fatty acids in the context of Parkinson’s disease. Neural Regeneration Research, 16(10), 2015. https://doi.org/10.4103/1673-5374.308089
• Misiura, M., & Miltyk, W. (2019). Proline-containing peptides-New insight and implications: A Review. BioFactors (Oxford, England), 45(6), 857–866. https://doi.org/10.1002/BIOF.1554
• Mozafar, M., Kazemian, S., Hoseini, E., Mohammadi, M., Alimoghadam, R., Shafie, M., & Mayeli, M. (2023). The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”. Clinical Parkinsonism and Related Disorders, 8. https://doi.org/10.1016/J.PRDOA.2022.100177
• Mucuna Pruriens Shows Neuroprotective Effect by Inhibiting Apoptotic Pathways of Dopaminergic Neurons in the Paraquat Mouse Model of Parkinsonism | Request PDF. (n.d.). Retrieved April 5, 2023, from https://www.researchgate.netpublication/341817981_MUCUNA_PRURIENS_SHOWS_NEUROPROTECTIVE_EFFECT_ BY_INHIBITING_APOPTOTIC_PATHWAYS_ OF_DOPAMINERGIC_NEURONS_IN_ THE_PARAQUAT_MOUSE_MODEL_OF_ PARKINSONISM
• Nagayama, H., Hamamoto, M., Ueda, M., Nito, C., Yamaguchi, H., & Katayama, Y. (2004). The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease. Clinical Neuropharmacology, 27(6), 270–273. https://doi. org/10.1097/01.WNF.0000150865.21759.BC
• Olanow, C. W., Stern, M. B., & Sethi, K. (2009). The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology, 72(21 Suppl 4). https://doi.org/10.1212/WNL.0B013E3181A1D44C Ortega-Arellano, H. F., Jimenez-Del-Rio, M., & Velez- Pardo, C. (2013). Dmp53, basket and drICE gene knockdown and polyphenol gallic acid increase life span and locomotor activity in a Drosophila Parkinson’s disease model. Genetics and Molecular Biology, 36(4), 608–615. https://doi.org/10.1590/ S1415-47572013000400020
• PANWAR, A. A. N. K. N. S. M. V. A. M. T. S. A. K. M. G.J. S. (2020). PHARMACOLOGICAL ACTIVITIES OF Mucuna pruriens: AN UPDATE. Plant Cell Biotechnology and Molecular Biology, 21(69–70).
• Pathania, R., Chawla, P., Khan, H., Kaushik, R., & Khan, M. A. (2020). An assessment of potential nutritive and medicinal properties of Mucuna pruriens: a natural food legume. 3 Biotech, 10(6), 261. https://doi.org/10.1007/S13205-020-02253-X
• Poroikov, V. V., Filimonov, D. A., Ihlenfeldt, W. D., Gloriozova, T. A., Lagunin, A. A., Borodina, Y. V., Stepanchikova, A. V., & Nicklaus, M. C. (2003). PASS biological activity spectrum predictions in the enhanced open NCI database browser. Journal of Chemical Information and Computer Sciences, 43(1), 228–236. https://doi.org/10.1021/CI020048R
• Quik, M., Parameswaran, N., McCallum, S. E., Bordia, T., Bao, S., McCormack, A., Kim, A., Tyndale, R. F., Langston, J. W., & Di Monte, D. A. (2006). Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates. Journal of Neurochemistry, 98(6), 1866–1875. https://doi.org/10.1111/J.1471-4159.2006.04078.X
• Rabiei, Z., Solati, K., & Amini-Khoei, H. (2019). Phytotherapy in treatment of Parkinson’s disease: a review. Pharmaceutical Biology, 57(1), 355–362. https://doi.org/10.1080/13880209.2019.1618344
• Savica, R., Rocca, W. A., & Ahlskog, J. E. (2010). When does Parkinson disease start? Archives of Neurology, 67(7), 798–801. https://doi.org/10.1001/ARCHNEUROL.2010.135
• Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017). Non-motor features of Parkinson disease. Nature Reviews. Neuroscience, 18(7), 435–450. https://doi.org/10.1038/NRN.2017.62
• Schommer, J., Marwarha, G., Nagamoto-Combs, K., & Ghribi, O. (2018). Palmitic Acid-Enriched Diet Increases α-Synuclein and Tyrosine Hydroxylase Expression Levels in the Mouse Brain. Frontiers in Neuroscience, 12(AUG). https://doi.org/10.3389/FNINS.2018.00552
• Science of Mucuna Pruriens for Treating Parkinson’s | APDA. (n.d.). Retrieved March 30, 2023, from https://www.apdaparkinson.org/article/mucuna- pruriens-for-parkinsons-disease/
• Serotonin.     (n.d.).       https://pubchem.ncbi.nlm.nih.gov/ compound/Serotonin
• Shimazu, S., & Miklya, I. (2004). Pharmacological studies with endogenous  enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28(3), 421–427. https://doi.org/10.1016/J.PNPBP.2003.11.016 Squalene. (n.d.). Stearic acid. (n.d.).
• Takeda, N. (1994). Serotonin-degradative pathways in the toad (Bufo bufo japonicus) brain: clues to the pharmacological analysis of human psychiatric disorders. Comparative Biochemistry and Physiology. Pharmacology, Toxicology and Endocrinology, 107(2), 275–281. https://doi.org/10.1016/1367-8280(94)90051-5
• Tan, N. H., Fung, S. Y., Sim, S. M., Marinello, E., Guerranti, R., & Aguiyi, J. C. (2009). The protective effect of Mucuna pruriens seeds against snake venom poisoning. Journal of Ethnopharmacology, 123(2), 356–358. https://doi.org/10.1016/J.JEP.2009.03.025
• Tavares, R. L., de Vasconcelos, M. H. A., Dutra, M. L. da V., D’oliveira, A. B., Lima, M. D. S., Salvadori, M. G. da S. S., Pereira, R. de A., Alves, A. F., Nascimento, Y. M. Do, Tavares, J. F., Guzman-Quevedo, O., & Aquino, J. de S. (2020). Mucuna pruriens Administration Minimizes Neuroinflammation and Shows Anxiolytic, Antidepressant and Slimming Effects in Obese Rats. Molecules, 25(23), 5559. https://doi.org/10.3390/MOLECULES25235559
• Tolosa, E., Vila, M., Klein, C., & Rascol, O. (2020). LRRK2 in Parkinson disease: challenges of clinical trials. Nature Reviews Neurology 2020 16:2, 16(2), 97–107. https://doi.org/10.1038/s41582-019-0301-2 Ubaid, S., Rumman, M., Singh, B., Akhtar, M. S.,
• Mahdi, A. A., & Pandey, S. (2020). Elucidating the Neuroprotective Role of Formulated Camel α-Lactalbumin-Oleic Acid Complex by Curating the SIRT1 Pathway in Parkinson’s Disease Model. ACS Chemical Neuroscience, 11(24), 4416–4425. https:// doi.org/10.1021/ACSCHEMNEURO.0C00639
• Voon, P. T., Ng, T. K. W., Lee, V. K. M., & Nesaretnam, K. (2011). Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. The American Journal of Clinical Nutrition, 94(6), 1451– 1457. https://doi.org/10.3945/AJCN.111.020107
• Wang, R., Sun, H., Wang, G., & Ren, H. (2020). Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson’s Disease. International Journal of Molecular Sciences, 21(19), 1–22. https://doi.org/10.3390/IJMS21197182
• Youdim, K. A., Martin, A., & Joseph, J. A. (2000). Essential fatty acids and the brain: possible health implications. International Journal of Developmental Neuroscience: The Official Journal of the International Society for Developmental Neuroscience, 18(4–5), 383–399. https://doi.org/10.1016/S0736-5748(00)00013-7